Hypertensive emergency

Revision as of 23:40, 1 March 2011 by Robot (talk | contribs)

Diagnosis

  • End-organ damage 2/2 increased BP (generally >180/120, usually > 220/130)
  • Brain - Encephelopathy, seizure, ICH, ischemic stroke
  • Eyes - Retinal hemorrhage, exudate, papilledema
  • CV - MI, CHF/LV failure/pulm edema, aortic dissection
  • Renal - Acute failure, hematuria, proteinuria
  • Ancillary Tests
  • Chemistry - assess renal failure
  • UA - Assess renal failure, glomerulo nephritis, preeclampsia
  • Troponin
  • CXR - Evidenceo failure, dissection
  • ECG


Etiology

  • Idiopathic
  • Sympathomimetic drug use
  • Preeclampsia
  • Acute glomerulonephritis


Treatment

  • Goal: Lower diastolic pressure to 105mmHg within 2-6 hours
  • Maximum initial fall in BP should not exceed 25% of presenting value
  • Be careful of lowering BP in pts with CVA!


Drug Dose Mechanism Pros Cons Notes Nitroprusside 0.25-8µg/kg/min

(start at 0.25)

Arterial and veno-dilator 1. Very effective

2. Immediate onset/offset

1. Cyanide Toxicity

2. Coronary steal?

3. Incr HR

1. Avoid in liver/renal failure

2. Avoid with incr ICP

3. Avoid in pregnancy


Nitgroglycerin 5-100 µg/min Veno>arteriodilation 1. Rapid on/offset

2. Increases coronary flow

Causes Tachycardia Drug of choice in pts w/ cardiac ischemia,

LV dysfunction, and pulm edema


Labetalol 20-80mg IV bolus q10min OR

0.5-2mg/min IV

Beta>alpha blocker 1. No change in HR, cerebral flow

2. Rapid onset

Avoid in COPD, CHF

heart block

1. Consider in ACS

2. Consider in ischemic CVA



Esmolol 250-500 µg/kg/min;

may repeat bolus after

5min or incr to 300µg/min

Beta selective 1. Rapid on/offset Avoid in COPD, CHF

bradycardia

Consider in ACS


Nicardipine 5-15mg/h Decreases PVR Good for intracranial pathology Slower onset/offset Avoid in CHF, ACS Hydralazine 5-10mg IV bolus, max dose 20mg OR 0.5-1mg/min IV infusion Arteriolar vasodilator Rarely causes hypotension Avoid in CAD Primarily used in pregancy Phentolamine 5-10mg IV bolus q5-15min OR

0.2-5mg/min IV infusion

Alpha blocker Used for catecholamine-induced HTN Enalapril 1.25mg over 5min q6hr Decreases HR, SV, systemic arterial pressure Does not impair cerebral flow Variable response 1. Used in pts at risk for cerebral hypotension, CHF

2. Avoid in pregnancy


Disease Specific

HTN Encephalopathy

    Controlled redxn of BP over 1h; never < 110 diastolic
         Labetolol, nicardipine, fenoldopam; nitroprusside of diastolic > 140


Stroke

    10-15% reduction of MAP; diastolic not < 110
    lower to 185/110 in ischemic stroke to meet t-PA criteria
         Labetolol, nicardipine, nitroprusside as above


Acute Aortic Dissection

    Rapid redxn of BP, systolic bp 100-120; HR 60-80 within 20mins
    Prevent reflex tachycardia
         Nitroprusside, fenoldopam, nicardipine with metoprolol or esmolol; labetolol alone


ACS and Pulmonary Edema

    Nitroglycerin


Eslampsia/Pre-eclampsia

    Labetolol, nicardipine or IV hydralazine
    Magnesium


Cocaine and Amphetamine Toxicitiy

    BDZs
    Mixed alpha + B blockade: phentolamine or nitroprusside plus beta blocker


Pheochromocytoma

    Phentolamine or nitroprusside plus beta blocker


ARF

    Fenoldopam, nicardipine; nitroprusside risk cyanide toxicity (renal metabolism)


Source

Adapted from Bessen, Bresler (ACEP '09), UpToDate